Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product namePinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade
SourceCAS 1313706-14-7
SpeciesHumanized
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPinatuzumab,ACD22-VCMMAE,DCDT2980S,FCU2803,RG-7593,RO5541072-000,CD22,anti-CD22
ReferencePX-TA1316
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Pinatuzumab Biosimilar - Anti-CD22 mAb - Research Grade

General information on Anti-CD22[Homo sapiens] (Pinatuzumab) Monoclonal Antibody

Pinatuzumab is investigated for the treatment of Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pinatuzumab Biosimilar – Anti-CD22 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD223 Recombinant Protein
Antigen

CD223 Recombinant Protein

PX-P4110 500$
Interferon-induced transmembrane protein 1(IFITM1)
Antigen

Interferon-induced transmembrane protein 1(IFITM1)

PX-P4692 250$
SIGLEC2 recombinant protein
Antigen

SIGLEC2 recombinant protein

PX-P5177 458$
IGF1R recombinant protein
Antigen

IGF1R recombinant protein

PX-P5185 500$
CD223 / LAG3, C-His, recombinant protein
Antigen

CD223 / LAG3, C-His, recombinant protein

PX-P5592 500$
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
Isotype Control

Human IgG1 LALA Isotype Control antibody (HyHEL-10)

PTX17885 214$

Contact us

Send us a message from the form below







    Cart (0 Items)

    Your cart is currently empty.

    View Products